- Filed
- Jul 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Jul 10, 2025 | 24.39M sh |
| Shares Diluted | FY 2025 · Mar 31, 2025 | 20.49M sh |
| Shares Diluted | FY 2025 · Mar 31, 2024 | 13.97M sh |
| Capex | FY 2025 · Mar 31, 2025 | $63.43K |
| Capex | FY 2025 · Mar 31, 2024 | $309.1K |
| Operating Cash Flow | FY 2025 · Mar 31, 2025 | −$5.32M |
| Operating Cash Flow | FY 2025 · Mar 31, 2024 | −$7.42M |
| Stockholders Equity | FY 2025 · Mar 31, 2025 | $4.22M |
| Stockholders Equity | FY 2025 · Mar 31, 2024 | $685.95K |
| Stockholders Equity | FY 2025 · Mar 31, 2023 | $725.03K |
| Current Liabilities | FY 2025 · Mar 31, 2025 | $4.32M |
| Current Liabilities | FY 2025 · Mar 31, 2024 | $1.41M |
| Total Liabilities | FY 2025 · Mar 31, 2025 | $5.12M |
| Total Liabilities | FY 2025 · Mar 31, 2024 | $2.43M |
| Current Assets | FY 2025 · Mar 31, 2025 | $5.61M |
| Current Assets | FY 2025 · Mar 31, 2024 | $1.04M |
| Total Assets | FY 2025 · Mar 31, 2025 | $9.34M |
| Total Assets | FY 2025 · Mar 31, 2024 | $3.12M |
| Eps Diluted | FY 2025 · Mar 31, 2025 | −$0.41 |
| Eps Diluted | FY 2025 · Mar 31, 2024 | −$0.78 |
| Eps Basic | FY 2025 · Mar 31, 2025 | −$0.41 |
| Eps Basic | FY 2025 · Mar 31, 2024 | −$0.78 |
| Sga Expense | FY 2025 · Mar 31, 2025 | $4.82M |
| Sga Expense | FY 2025 · Mar 31, 2024 | $6.69M |
| Rd Expense | FY 2025 · Mar 31, 2025 | $1.58M |
| Rd Expense restated | FY 2025 · Mar 31, 2024 | $1.4M |
| Net Income | FY 2025 · Mar 31, 2025 | −$8.4M |
| Net Income | FY 2025 · Mar 31, 2024 | −$10.96M |
| Operating Income | FY 2025 · Mar 31, 2025 | −$8.06M |
| Operating Income | FY 2025 · Mar 31, 2024 | −$10.62M |
| Gross Profit | FY 2025 · Mar 31, 2025 | $994.86K |
| Gross Profit restated | FY 2025 · Mar 31, 2024 | $866.88K |
| Revenue | FY 2025 · Mar 31, 2025 | $1.13M |
| Revenue | FY 2025 · Mar 31, 2024 | $968.71K |